Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 1/20 | 0.35 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.35 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.35 |
| ▸ | NCEH1 | Q6PIU2 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | VDR | P11473 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29053723 | 0.87 | KIF11 (0.41) | KIF11CCNB2CDK1CCNB1CCNB3 | |
| SCHEMBL4355031 | 0.81 | RECQL (0.36) | NCEH1POLBCYP1A2ALDH1A1 | |
| SCHEMBL1070380 | 0.78 | KIF11 (0.40) | KIF11CCNB2CDK1CCNB1CCNB3 | |
| SCHEMBL17539919 | 0.78 | TSHR (0.41) | GABRA1GABRB2ALDH1A1 | |
| SCHEMBL28511 | 0.78 | ALDH1A1 (0.44) | POLBCYP1A2ALDH1A1GPR3HSD17B10 | |
| SCHEMBL29352635 | 0.78 | ALDH1A1 (0.44) | POLBCYP1A2ALDH1A1GPR3HSD17B10 | |
| SCHEMBL25060809 | 0.75 | CCNB2 (0.39) | KIF11CCNB2CDK1CCNB1CCNB3 | |
| SCHEMBL7915432 | 0.74 | POLB (0.42) | POLBCYP1A2ALDH1A1GPR3HSD17B10 | |
| SCHEMBL18473313 | 0.71 | ACHE (0.47) | CCNB2CDK1CCNB1CCNB3ALDH1A1 | |
| SCHEMBL12898148 | 0.71 | NCEH1 (0.37) | KIF11CCNB2CDK1CCNB1CCNB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8357821-B2 | Aromatic amine compound, organic electroluminescent element including the same, and display device including organic electroluminescent element | SONY CORPORATION (JP) | 2013-01-22 | — | — | US | disclosed |
| CN-101735107-A | Aromatic amine compound, organic electroluminescent element including the same, and display device including organic electroluminescent element | SONY CORP | 2010-06-16 | — | — | CN | disclosed |
| US-20100109555-A1 | AROMATIC AMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING ORGANIC ELECTROLUMINESCENT ELEMENT | SONY CORPORATION (JP) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100109555-A1 | AROMATIC AMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING ORGANIC ELECTROLUMINESCENT ELEMENT | AOC2, NR2E1, AOC3 | KIF11 3001/4885CCNB2 468/4885CDK1 1537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.